Time for united action on depression: a Lancet–World Psychiatric Association Commission

H Herrman, V Patel, C Kieling, M Berk, C Buchweitz… - The Lancet, 2022 - thelancet.com
Executive summary “Depression is a disorder of mood, so mysteriously painful and elusive
in the way it becomes known to the self—to the mediating intellect—as to verge close to …

Combining antidepressants vs antidepressant monotherapy for treatment of patients with acute depression: a systematic review and meta-analysis

J Henssler, D Alexander, G Schwarzer, T Bschor… - JAMA …, 2022 - jamanetwork.com
Importance Combining antidepressants is frequently done in the treatment of acute
depression, but studies have yielded conflicting results. Objective To conduct a systematic …

The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

GS Malhi, E Bell, D Bassett, P Boyce… - Australian & New …, 2021 - journals.sagepub.com
Objectives: To provide advice and guidance regarding the management of mood disorders,
derived from scientific evidence and supplemented by expert clinical consensus to formulate …

Nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder: a living clinical guideline from the American College of …

A Qaseem, DK Owens… - Annals of internal …, 2023 - acpjournals.org
An update is available for this article. Description: The purpose of this guideline from the
American College of Physicians (ACP) is to present updated clinical recommendations on …

Impact of CYP2C19 metaboliser status on SSRI response: a retrospective study of 9500 participants of the Australian Genetics of Depression Study

AI Campos, EM Byrne, BL Mitchell, NR Wray… - The …, 2022 - nature.com
Background Variation within the CYP2C19 gene has been linked to differential metabolism
of selective serotonin reuptake inhibitors (SSRIs). Pharmacogenetic recommendations …

[HTML][HTML] Depression in sub-saharan Africa

IT Gbadamosi, IT Henneh, OM Aluko… - IBRO neuroscience …, 2022 - Elsevier
Mood disorders can be considered among the most common and debilitating mental
disorders. Major depression, as an example of mood disorders, is known to severely reduce …

Nonpharmacologic and pharmacologic treatments of adult patients with major depressive disorder: a systematic review and network meta-analysis for a clinical …

G Gartlehner, A Dobrescu, A Chapman… - Annals of internal …, 2023 - acpjournals.org
An update is available for this article. Background: Primary care patients and clinicians may
prefer alternative options to second-generation antidepressants for major depressive …

FORWARD study: evaluating the comparative effectiveness of onabotulinumtoxinA and topiramate for headache prevention in adults with chronic migraine

JF Rothrock, AM Adams, RB Lipton… - … : The Journal of …, 2019 - Wiley Online Library
Objective To compare effectiveness of onabotulinumtoxinA and topiramate for chronic
migraine (CM) prevention. Background The efficacy* of onabotulinumtoxinA and topiramate …

Sex differences in the behavioral, molecular, and structural effects of ketamine treatment in depression

E Ponton, G Turecki, C Nagy - International Journal of …, 2022 - academic.oup.com
Major depressive disorder (MDD) is a common psychiatric illness that manifests in sex-
influenced ways. Men and women may experience depression differently and also respond …

Designing clinically useful psychopharmacological trials: challenges and ways forward

A Chevance, P Ravaud, V Cornelius… - The Lancet …, 2022 - thelancet.com
The clinical guidelines that underpin the use of drugs for mental disorders are informed by
evidence from randomised controlled trials (RCTs). RCTs are performed to obtain marketing …